The Australian market has had a cautious start to the week, with most sectors in the red and only staples and energy showing strength. In such a fluctuating landscape, identifying stocks that combine solid financials with growth potential becomes crucial. Penny stocks, though often overlooked due to their size, can offer unique opportunities for those willing to explore smaller or newer companies with strong financial health.
Top 10 Penny Stocks In Australia
Name | Share Price | Market Cap | Rewards & Risks |
Alfabs Australia (ASX:AAL) | A$0.455 | A$130.4M | ✅ 4 ⚠️ 3 View Analysis > |
EZZ Life Science Holdings (ASX:EZZ) | A$2.47 | A$116.52M | ✅ 4 ⚠️ 2 View Analysis > |
IVE Group (ASX:IGL) | A$2.77 | A$427.08M | ✅ 4 ⚠️ 2 View Analysis > |
SHAPE Australia (ASX:SHA) | A$4.18 | A$344.2M | ✅ 3 ⚠️ 1 View Analysis > |
West African Resources (ASX:WAF) | A$2.90 | A$3.31B | ✅ 4 ⚠️ 1 View Analysis > |
LaserBond (ASX:LBL) | A$0.515 | A$60.59M | ✅ 4 ⚠️ 1 View Analysis > |
Bravura Solutions (ASX:BVS) | A$2.30 | A$1.03B | ✅ 3 ⚠️ 3 View Analysis > |
Praemium (ASX:PPS) | A$0.745 | A$356.27M | ✅ 5 ⚠️ 2 View Analysis > |
MaxiPARTS (ASX:MXI) | A$2.44 | A$135.29M | ✅ 3 ⚠️ 2 View Analysis > |
CTI Logistics (ASX:CLX) | A$1.8625 | A$150.01M | ✅ 4 ⚠️ 2 View Analysis > |
Click here to see the full list of 450 stocks from our ASX Penny Stocks screener.
We're going to check out a few of the best picks from our screener tool.
Adore Beauty Group (ASX:ABY)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Adore Beauty Group Limited operates an integrated content, marketing, and e-commerce retail platform in Australia and New Zealand with a market cap of A$108.05 million.
Operations: The company generates revenue of A$198.8 million from selling beauty and personal care products via its online platform.
Market Cap: A$108.05M
Adore Beauty Group Limited, with a market cap of A$108.05 million, reported full-year sales of A$198.8 million and net income of A$2.6 million for the fiscal year ending June 30, 2025. The company has shown consistent earnings growth, outperforming the Specialty Retail industry with a 19.5% increase over the past year and maintaining profitability over five years with an average annual growth rate of 6.8%. Despite experiencing a large one-off loss impacting recent results, Adore Beauty remains debt-free and trades below its estimated fair value while possessing strong short-term asset coverage for liabilities.
- Take a closer look at Adore Beauty Group's potential here in our financial health report.
- Assess Adore Beauty Group's future earnings estimates with our detailed growth reports.
Praemium (ASX:PPS)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Praemium Limited, with a market cap of A$356.27 million, offers advisors and wealth management solutions through a seamless digital platform in Australia and internationally.
Operations: Praemium does not report specific revenue segments.
Market Cap: A$356.27M
Praemium Limited, with a market cap of A$356.27 million, has demonstrated significant earnings growth of 55% over the past year, surpassing the Software industry average. The company reported full-year sales of A$103.04 million and net income of A$13.56 million for the fiscal year ending June 30, 2025, reflecting an improvement from the previous year. Praemium remains debt-free and trades at a good value compared to peers and its estimated fair value. Despite stable weekly volatility and experienced management and board teams, it faced a large one-off loss impacting recent financial results while maintaining strong short-term asset coverage for liabilities.
- Navigate through the intricacies of Praemium with our comprehensive balance sheet health report here.
- Examine Praemium's earnings growth report to understand how analysts expect it to perform.
SRG Global (ASX:SRG)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: SRG Global Limited operates as an engineering, mining, maintenance and construction contracting company in Australia and New Zealand, with a market cap of A$1.18 billion.
Operations: The company's revenue is derived from Engineering and Construction, which contributes A$455.93 million, and Maintenance and Industrial Services, which accounts for A$867.38 million.
Market Cap: A$1.18B
SRG Global Limited, with a market cap of A$1.18 billion, has shown robust financial health and growth. The company reported full-year sales of A$1.32 billion, up from A$1.07 billion the previous year, and net income increased to A$47.48 million from A$34.44 million. Despite a low return on equity at 12.1%, SRG's earnings have grown significantly over five years by 50% annually on average, although recent growth decelerated to 37.9%. The company's debt is well-covered by operating cash flow and interest payments are comfortably managed by EBIT (44x coverage). SRG is strategically positioned for both organic and inorganic growth through potential acquisitions while maintaining a strong balance sheet that supports such endeavors.
- Get an in-depth perspective on SRG Global's performance by reading our balance sheet health report here.
- Explore SRG Global's analyst forecasts in our growth report.
Where To Now?
- Unlock more gems! Our ASX Penny Stocks screener has unearthed 447 more companies for you to explore.Click here to unveil our expertly curated list of 450 ASX Penny Stocks.
- Contemplating Other Strategies? The latest GPUs need a type of rare earth metal called Dysprosium and there are only 27 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Praemium might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com